Synapse - Works

Results (1933)

A "first in man" study of the safety and PK/PD of an oral FLT3 inhibitor (MLN518) in patients with AML or high risk myelodysplasia

Meeting Abstract

Heinrich, M. C.; Druker, B. J.; Curtin, P. T.; Paquette, R.; Sawyers, C. L.; De Angelo, D. J.; Gilliland, G. D.; Stone, R. M.; Caliguiri, M. A.; Byrd, J. C.; more...
Blood (2002)

Fulltext@MSK | Save

Characteristics of patients with relapsed and refractory low grade non-Hodgkin's lymphoma who sustained durable responses following treatment with tositumomab and iodine I 131 tositumomab (Bexxar (R))

Meeting Abstract

Gregory, S. A.; Kaminski, M. S.; Zelenetz, A. D.; Jain, V.
Blood (2002)

Fulltext@MSK | Save

TGF beta induced growth arrest of human hematopoietic cells requires p57KIP2 upregulation

Meeting Abstract

Scandura, J. M.; Boccuni, P.; Nimer, S. D.
Blood (2002)

Fulltext@MSK | Save

Clinical experience of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in heavily pre-treated patients with aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)

Meeting Abstract

O'Connor, O. A.; Richon, V.; Moskowitz, C. H.; Zelenetz, A. D.; Macgregor-Cortelli, B.; Curly, T.; Richardson, S.; Tong, W.; Rifkind, R.; Marks, P.; more...
Blood (2002)

Fulltext@MSK | Save

A phase II, open-label study of CLOFAREX(TM) in pediatric patients with refractory or relapsed acute-myelogenous or lymphoblastic leukemia

Meeting Abstract

Jeha, S.; Steinherz, P.; Altman, S.; Rheingold, S.; Gaynon, P.; Goldman, S.; Craig, A.; Weiss, J.; Arceci, R.
Blood (2002)

Fulltext@MSK | Save

Allogeneic bone marrow transplantation (BMT) for the treatment of homozygous beta thalassemia (HB-Thal) - The MSKCC experience

Meeting Abstract

Boulad, F.; Giardina, P.; Small, T. N.; Prasad, V.; Casson, A.; Torok-Castanza, J.; Duschock, B.; Kernan, N. A.; O'Reilly, R. J.
Blood (2002)

Fulltext@MSK | Save

Epoetin alfa treatment improves quality of life and increases hemoglobin levels during chemotherapy for lymphoma, chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) patients with mild-to-moderate anemia

Meeting Abstract

Straus, D. J.; Turner, R. R.; Testa, M. A.; Hayes, J. F.; Sarokhan, B. J.
Blood (2002)

Fulltext@MSK | Save

Long-term in vivo monitoring of the tumor targeted migration of EBV specific cytotoxic T-cells transduced to express HSV-TK by PET scan following repeated in vivo labeling with [I-124]FIAU

Meeting Abstract

Doubrovina, E. S.; Doubrovin, M. M.; Ivanova, A.; Ageyeva, L.; Balatoni, J.; Beresten, T.; Finn, R.; Larson, S.; Sadelain, M.; Blasberg, R.; more...
Blood (2002)

Fulltext@MSK | Save

Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T-cells after allogeneic stem cell transplantation identifies patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

Meeting Abstract

van Esser, J. W. J.; Meij, P.; Niesters, H. G. M.; van Baarle, D.; Miedema, F.; Blake, N.; Rickinson, A. B.; Leiner, I.; Pamer, E.; Löwenberg, B.; more...
Blood (2002)

Fulltext@MSK | Save

A TVA-based retroviral gene delivery system for the in vivo analysis of multistep leukemogenesis in the mouse

Meeting Abstract

Wu, X.; Pandolfi, P. P.
Blood (2002)

Fulltext@MSK | Save